Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy

Dominik Dytfeld; Magdalena Łuczak; Tomasz Wróbel; Lidia Usnarska-Zubkiewicz; Katarzyna Brzezniakiewicz; Krzysztof Jamroziak; Krzysztof Giannopoulos; Anna Przybyłowicz-Chałecka; Błażej Ratajczak; Joanna Czerwińska-Rybak; Adam Nowicki; Monika Joks; Elżbieta Czechowska; Magdalena Zawartko; Tomasz Szczepaniak; Norbert Grzasko; Marta Morawska; Maciej Bochenek; Tadeusz Kubicki; Michalina Morawska; Katarzyna Tusznio; Andrzej Jakubowiak; Mieczysław Komarnicki

doi:10.18632/oncotarget.11059

Scientific Information System of the Poznań University of Technology

PL EN

Main page / Publications / Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy

Submit a comment

Article

Download BibTeX

Title

Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy

Authors

| ^{[ P ]} employee

Year of publication

2016

Published in

Oncotarget

Journal year: 2016 | Journal volume: vol. 7 | Journal number: iss. 35

Article type

scientific article

Publication language

english

Keywords

EN

multiple myeloma
bortezomib
label-free proteomics
itraq
thioredoxin

Pages (from - to)

56726 - 56736

DOI

10.18632/oncotarget.11059

Ministry points / journal

40

Impact Factor

5,168

System created by Poznań University of Technology and Poznan Supercomputing and Networking Center

Log in through eKonto to add to SIS